It has something to do with the high cost of R&D, and the 17-year patent expiration. As soon as the patent expires on a new drug, other companies may use the formula, selling the drug for a small margin above their manufacturing costs, and cutting the original developer out of the picture. It costs millions to develop a new drug and to get it through the regulatory agencies - clinical trials, bribing government officials, etc.
New words, one handy idiom, and a 2-minute quiz — delivered to your inbox to keep your streak alive.